Skip to main content

Table 1 Demographic data collected at the baseline

From: Ultrasonography evaluation on the protective effect of combination therapy of beraprost sodium and aspirin on arteries occlusion and stiffness in patients with type 2 diabetes mellitus - a prospective, randomized study

Variables

Combined therapy group (n=32)

Aspirin group (n=32)

P

 

Mean

Std

Mean

Std

 

Age (year)

62.7

6.4

64.4

6.5

0.338

Male Sex (%)

63.0%

/

65.4%

/

0.541

BMI (kg/m2)

24.71

3.12

24.03

3.28

0.442

SBP (mmHg)

142.56

15.92

149.05

15.41

0.138

DBP (mmHg)

74.90

8.04

77.94

7.48

0.160

HbA1C (%)

6.93

0.77

6.91

0.67

0.928

FBG (mmol/L)

6.99

2.76

6.62

1.67

0.556

CHOL (mmol/L)

5.12

0.85

5.21

0.91

0.722

TG (mmol/L)

1.52

0.68

2.02

1.47

0.118

HDL-C (mmol/L)

1.34

0.31

1.39

0.34

0.644

LDL-C (mmol/L)

3.09

0.76

2.91

0.95

0.446

AST (U/L)

20.74

4.43

27.88

16.11

0.031

ALT (U/L)

17.00

8.22

25.62

18.07

0.029

BUN (mmol/L)

6.96

1.87

6.53

1.89

0.407

CREA (μmol/L)

108.63

21.09

106.04

25.10

0.685

CCR (ml/min)

56.10

12.98

55.99

16.80

0.980

Medication use

 Antihypertensive drugs (%)

90.63

/

90.63

/

1.000

 Insulin (%)

68.75

/

65.63

/

0.790

 Statins (%)

15.63

/

18.75

/

0.740

  1. Plus-minus values are mean±S.D